Condensed Consolidated Statement of Changes in Shareholders' Interest (Deficit) (USD $)	Preferred Stock	Common Stock	Capital in excess of par value	Receivable from Crisnic Fund	Accumulated deficit	Total shareholders' interest (deficit)
Stockholder's Equity December 31, 2010 at Dec. 31, 2010	$ 60,675	$ 138,249	$ 43,484,989	$ (22,500)	$ (43,010,053)	$ 651,360
Shares Outstanding December 31, 2010 at Dec. 31, 2010	2,427	13,824,944
Net income (loss)					(1,843,060)	(1,843,060)
Common shares issued from the exercise of stock option grants (value)		100	9,950			10,050
Common shares issued from the exercise of stock option grants (shares)		10,000
Return of shares issued to Crisnic (value)		(250)	(22,250)	22,500
Return of shares issued to Crisnic (shares)		(25,000)
Common shares issued to settle accounts payable, general and accrued expenses (value)		1,750	215,100			216,850
Common shares issued to settle accounts payable, general and accrued expenses (shares)		175,000
Conversion of Series C Convertible Preferred Stock (value)		3,151	453,782			456,933
Conversion of Series C Convertible Preferred Stock (shares)		315,126
Common stock issued to directors (value)		192	30,608			30,800
Common stock issued to directors (shares)		19,219
Compensation expense from stock option grants (value)			67,639			67,639
Stockholder's Equity September 30, 2011 at Sep. 30, 2011	$ 60,675	$ 143,192	$ 44,239,818		$ (44,853,113)	$ (409,428)
Shares Outstanding September 30, 2011 at Sep. 30, 2011	2,427	14,319,289